Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017

Details for Mechanism ID: 17000
Country/Region: Ethiopia
Year: 2017
Main Partner: Tigray Regional Health Bureau - Ethiopia
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $4,465,809 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $655,520
Care: TB/HIV (HVTB) $212,102
Care: Pediatric Care and Support (PDCS) $227,646
Laboratory Infrastructure (HLAB) $84,000
Strategic Information (HVSI) $50,050
Testing: HIV Testing and Counseling (HVCT) $93,186
Sexual Prevention: Other Sexual Prevention (HVOP) $85,264
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $178,398
Treatment: Adult Treatment (HTXS) $2,618,908
Treatment: Pediatric Treatment (PDTX) $260,735
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 195
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 157
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 208
GEND_GBV Number of people receiving post-GBV care 2018 365
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 371,934
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 14,966
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 17,591
HTS_TST Service Delivery Point Agg Age (Facility) ANC: 15+, Negative 2018 75,714
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 176
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 169
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 537
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 537
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Negative 2018 12,918
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Negative 2018 16,648
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 32,600
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 28,885
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Negative 2018 5,817
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Negative 2018 5,818
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 51,704
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 48,551
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Female, Negative 2018 1,862
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Male, Negative 2018 1,862
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Female, Negative 2018 5,676
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Male, Negative 2018 5,649
HTS_TST Service Delivery Point Agg Age (Facility) VCT: <15, Female, Negative 2018 1,862
HTS_TST Service Delivery Point Agg Age (Facility) VCT: <15, Male, Negative 2018 1,862
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Negative 2018 19,844
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Negative 2018 17,235
HTS_TST Sum of Test Result disaggregates 2018 5,080
HTS_TST_POS By Test Result: Positive 2018 5,080
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 64
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 64
HTS_TST_POS Service Delivery Point Agg Age (Facility) ANC: 15+, Positive 2018 443
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 10
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 12
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 28
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 28
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Positive 2018 27
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Positive 2018 153
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 696
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 587
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Positive 2018 58
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Positive 2018 58
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 963
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 725
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: <15, Female, Positive 2018 26
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: <15, Male, Positive 2018 26
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Female, Positive 2018 82
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Male, Positive 2018 82
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: <15, Female, Positive 2018 28
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: <15, Male, Positive 2018 8
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Positive 2018 437
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Positive 2018 385
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 1,221
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 1,221
PMTCT_ART Already on ART at beginning of current pregnancy 2018 1,040
PMTCT_ART New on ART 2018 398
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 1,438
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 72,471
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 1,438
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 278
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 1,098
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 9
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 53
PMTCT_STAT By Age (Numerator): 15-19 2018 3,647
PMTCT_STAT By Age (Numerator): 20-24 2018 25,509
PMTCT_STAT By Age (Numerator): 25-49 2018 43,722
PMTCT_STAT By Number of known positives: 15-19 2018 53
PMTCT_STAT By Number of known positives: 20-24 2018 382
PMTCT_STAT By Number of known positives: 25-49 2018 653
PMTCT_STAT By Number of new negative: 15-19 2018 3,559
PMTCT_STAT By Number of new negative: 20-24 2018 24,835
PMTCT_STAT By Number of new negative: 25-49 2018 42,570
PMTCT_STAT By Number of new positives: 15-19 2018 14
PMTCT_STAT By Number of new positives: 20-24 2018 149
PMTCT_STAT By Number of new positives: 25-49 2018 257
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 72,471
PMTCT_STAT_den By Age (Denominator): <15-19 2018 3,815
PMTCT_STAT_den By Age (Denominator): 20-24 2018 26,701
PMTCT_STAT_den By Age (Denominator): 25-49 2018 45,770
PP_PREV Age/sex: 10-14 Female 2018 101
PP_PREV Age/sex: 15-19 Female 2018 1,176
PP_PREV Age/sex: 15-19 Male 2018 544
PP_PREV Age/sex: 20-24 Female 2018 3,188
PP_PREV Age/sex: 20-24 Male 2018 1,298
PP_PREV Age/sex: 25-49 Female 2018 7,068
PP_PREV Age/sex: 25-49 Male 2018 2,891
PP_PREV Age/sex: 50+ Female 2018 351
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 17,716
PP_PREV Sum of Age/Sex disaggregates 2018 16,617
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 10
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 196
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 15
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 291
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 512
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 512
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 10
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 196
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 15
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 292
TB_PREV By Age/Sex (Numerator): <15, Female 2018 135
TB_PREV By Age/Sex (Numerator): <15, Male 2018 145
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 2,643
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 1,738
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 4,661
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 4,661
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 5,174
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 150
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 163
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 2,928
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 1,933
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 5,174
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 326
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 2,162
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 369
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 2,529
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 5,386
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 5,553
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 330
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,220
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 379
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,624
TX_CURR Aggregated Age/Sex: <15 Female 2018 1,166
TX_CURR Aggregated Age/Sex: <15 Male 2018 1,243
TX_CURR Aggregated Age/Sex: 15+ Female 2018 24,506
TX_CURR Aggregated Age/Sex: 15+ Male 2018 16,071
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 42,986
TX_CURR Sum of Aggregated Age/Sex <15 2018 2,409
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 40,577
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 42,986
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 187
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 213
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 3,330
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 2,185
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 5,915
TX_NEW Pregnancy status 2018 187
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 5,915
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 53,762
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 30,434
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 441
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 213
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 469
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 226
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 14,584
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 2,970
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 9,578
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,951
TX_PVLS Numerator: Indication: Routine 2018 25,072
TX_PVLS Numerator: Indication: Targeted 2018 5,362
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 625
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 264
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 666
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 280
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 16,196
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 4,569
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 10,631
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 2,987
TX_PVLS_den Denominator: Indication: Routine 2018 28,118
TX_PVLS_den Denominator: Indication: Targeted 2018 8,110
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 179
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 201
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 3,055
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,014
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 5,449
TX_RET Numerator by Status: Pregnant 2018 173
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 5,915
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 188
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 211
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 3,330
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,186
TX_RET_den Denominator by Status: Pregnant 2018 187
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 38,688
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 618
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 20
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 27
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 244
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 327
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 1,938
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 2,325
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 15,859
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 18,566
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 1,742
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 350
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 1,401
TX_TB_den Denominator: By Screen Result: Negative 2018 34,815
TX_TB_den Denominator: By Screen Result: Positive 2018 3,873
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 3,493
Cross Cutting Budget Categories and Known Amounts Total: $348,331
Gender: Gender Based Violence (GBV) $20,721
GBV Prevention
Water $21,400
Renovation $306,210